LXRX
Lexicon Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$677.89M
P/E Ratio
—
EPS
$-0.14
Beta
0.95
52W High
$1.83
52W Low
$0.47
50-Day MA
$1.51
200-Day MA
$1.30
Dividend Yield
—
Profit Margin
-101.10%
Forward P/E
—
PEG Ratio
-0.14
About Lexicon Pharmaceuticals Inc
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of pharmaceutical products. The company is headquartered in The Woodlands, Texas.
Fundamentals
| Revenue (TTM) | $49.80M |
| Gross Profit (TTM) | $43.24M |
| EBITDA | $-48.29M |
| Operating Margin | -269.10% |
| Return on Equity | -39.70% |
| Return on Assets | -12.70% |
| Revenue/Share (TTM) | $0.14 |
| Book Value | $0.30 |
| Price-to-Book | 6.26 |
| Price-to-Sales (TTM) | 13.61 |
| EV/Revenue | 12.86 |
| EV/EBITDA | 16.57 |
| Quarterly Earnings Growth (YoY) | -63.40% |
| Quarterly Revenue Growth (YoY) | -79.30% |
| Shares Outstanding | $423.68M |
| Float | $417.80M |
| % Insiders | 1.03% |
| % Institutions | 68.49% |
Analyst Ratings
Consensus ($3.36 target)
1
Strong Buy2
Buy2
HoldData last updated: 4/8/2026